AR and gastric cancer: The roles of these increased β-catenin and RAS levels in the resistance and reoccurrence of GC upon the chemotherapy were indicated by the up-regulations of both β-catenin and RAS in the PR- and AR-PDX tumors after FOLFOX treatment.